Interleukin-1β and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice

American Journal of Pathology

Volumn 168, Issue 4, 2006, Pages 1396-1403

  Chamberlain, Janet ^a   Evans, David ^a   King, Andrea ^a   Dewberry, Rachael ^a   Dower, Steven ^a   Crossman, David ^a   Francis, Sheila ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PURINE P2X7 RECEPTOR; INTERLEUKIN 1 RECEPTOR; PURINE P2 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; BLOOD VESSEL WALL; CAROTID ARTERY LIGATION; CHIMERA; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MODEL; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CAROTID ARTERY OBSTRUCTION; COMMON CAROTID ARTERY; GENETICS; INTIMA; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CAROTID ARTERY, COMMON; CAROTID STENOSIS; CASPASE 1; CHIMERA; INTERLEUKIN-1; MICE; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-1; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; TUNICA INTIMA;

EID: 33645454887     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.051054     Document Type: Article

References (38)

1. Chamberlain J, Gunn J, Francis S, Holt C, Crossman D: Temporal and spatial distribution of interleukin-1 beta in balloon injured porcine coronary arteries. Cardiovasc Res 1999, 44:156-165
2. Bourcier T, Dockter M, Hassid A: Synergistic interaction of interleukin-1 beta and growth factors in primary cultures of rat aortic smooth muscle cells. J Cell Physiol 1995, 164:644-657
3. Scott-Burden T, Schini VB, Elizondo E, Junquero DC, Vanhoutte PM: Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. Circ Res 1992, 71:1088-1100
4. Raines EW, Dower SK, Ross R: Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 1989, 243:393-396
5. Shimokawa H, Ito A, Fukumoto Y, Kadokami T, Nakaike R, Sakata M, Takayanagi T, Egashira K, Takeshita A: Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. J Clin Invest 1996, 97:769-776
6. Rectenwald JE, Moldawer LL, Huber TS, Seeger JM, Ozaki CK: Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 2000, 102:1697-1702
7. Isoda K, Shiigai M, Ishigami N, Matsuki T, Horai R, Nishikawa K, Kusuhara M, Nishida Y, Iwakura Y, Ohsuzu F: Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury. Circulation 2003, 108:516-518
8. Morton AC, Arnold ND, Gunn J, Varcoe R, Francis SE, Dower SK, Crossman DC: Interleukin-1 receptor antagonist alters the response to vessel wall injury in a porcine coronary artery model. Cardiovasc Res 2005, 68:493-501
9. Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, Koller BH, Griffiths RJ, Gabel CA: Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 2001, 276:125-132
10. Li P, Allen H, Banerjee S, Seshadri T: Characterization of mice deficient in interleukin-1 beta converting enzyme. J Cell Biochem 1997, 64:27-32
11. Dinarello C.A: Interleukin-1 Family [IL-1F1, F2]. Edited by Dinarello CA. London, Elsevier Science Ltd., 2003, pp 643-708
12. Campbell GR, Campbell JH, Manderson JA, Horrigan S, Rennick RE: Arterial smooth muscle: a multifunctional mesenchymal cell. Arch Pathol Lab Med 1988, 112:977-986
13. Thyberg J, Hedin U, Sjolund M, Palmberg L, Bottger BA: Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 1990, 10:966-990
14. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, Wilcox JN: Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 1996, 93:2178-2187
15. Shi Y, O'Brien JE, Fard A, Mannion JD, Zalewski A: Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996, 94:1655-1664
16. Han CI, Campbell GR, Campbell JH: Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res 2001, 38:113-119
17. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R: Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002, 8:403-409
18. Campbell JH, Han CL, Campbell GR: Neointimal formation by circulating bone marrow cells. Ann NY Acad Sci 2001, 947:18-24
19. Glaccum MB, Stocking KL, Charrier K, Smith JL, Willis CR, Maliszewski C, Livingston DJ, Peschon JJ, Morrissey PJ: Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol 1997, 159:3364-3371
20. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J: Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 1995, 80:401-411
21. Sim J, Young MT, Sung HY, North RA, Surprenant A: Re-analysis of P2X7 receptor expression in rodent brain. J Neurosci 2004, 24:6307-6314
22. Horai R, Asano M, Sudo K, Kanuka H, Suzuki M, Nishihara M, Takahashi M, Iwakura Y: Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med 1998, 187:1463-1475
23. Neta R, Oppenheim JJ, Wang J-M, Snapper CM, Moorman MA, Dubois CM: Synergy of IL-1 and stem cell factor in radioprotection of mice is associated with IL-1 up-regulation of mRNA and protein expression for c-kit on bone marrow cells. J Immunol 1994, 153:1536-1543
24. Neta R: Modulation with cytokines of radiation injury: suggested mechanisms of action. Environ Health Perspect 1997, 105(Suppl 6):1463-1465
25. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J, Ding GJ-F, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju SM, Rolando AM, Salley JP, Yamin T-T, Lee TD, Shively JE, MacCross M, Mumford RA, Schmidt JA, Tocci M: A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 1992, 356:768-774
26. Young PR, Hazuda DJ, Simon PL: Human interleukin-1β is not secreted from hamster fibroblasts when expressed constitutively from a transfected cDNA. J Cell Biol 1988, 107:447-456
27. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA, Huebner K, Black RA: Molecular cloning of the interleukin-1β converting enzyme. Science 1992, 156:97-100
28. Black RA, Kronheim SR, Cantrell M, Deeley MC, March CJ, Prickett KS, Wignall J, Conlon PJ, Cosman D, Hopp TP, Mochizuki DY: Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem 1988, 263:9437-9442
29. Dinarello CA, Cannon JG, Mier JW, Bernheim HA, LoPreste G, Lynn DL, Love RN, Webb AC, Auron PE, Reuben RC, Rich A, Wolff SM, Putney SD: Multiple biological activities of human recombinant interleukin 1. J Clin Invest 1986, 77:1734-1739
30. Hazuda DJ, Strickler J, Kueppers F, Simon PL, Young PR: Processing of precursor interleukin-1 beta and inflammatory disease. J Biol Chem 1990, 265:6318-6322
31. Irmler M, Hertig S, MacDonald HR, Sadoul R, Becherer JD, Proudfoot A, Solari R, Tschopp J: Granzyme A is an interleukin-1β-converting enzyme. J Exp Med 1995, 181:1917-1922
32. Knudsen PJ, Dinarello CA, Strom TB: Purification and characterisation of a unique human interleukin-1 from the tumour cell line U937. J Immunol 1986, 136:3311-3316
33. Mizutani H, Schechter N, Lazarus G, Black RA, Kupper TS: Rapid and specific conversion of precursor interleukin-1β (IL-1β) to an active IL-1 species by human mast cell chymase. J Exp Med 1991, 174:821-825
34. Coeshott C, Ohnemus C, Pilyavskaya A, Ross S, Wieczorek M, Kroona H, Leimer AH, Cheronis J: Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci USA 1999, 96:6261-6266
35. Fantuzzi G, Ku G, Harding MW, Livingston DJ, Sipe JD, Kuida K, Flavell RA, Dinarello CA: Response to local inflammation of IL-1 beta-converting enzyme-deficient mice. J Immunol 1997, 158:1818-1824
36. Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Melchiorri L, Baricordi OR, Di Virgilio F: Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol 1997, 159:1451-1458
37. Wilson HL, Francis SE, Dower SK, Crossman DC: Secretion of intracellular IL-1 receptor antagonist (type 1) is dependent on P2X7 receptor activation. J Immunol 2004, 173:1202-1208
38. Dewberry R, Holden H, Crossman D, Francis S: Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol 2000, 20:2394-2400